Key Developments: Farmsintez OAO (LIFE.RTS)

LIFE.RTS on Russian Trading System (Paufor)

Price Change (% chg)

0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Farmsintez OAO builds biotechnological plant in Belarus as part of PrimeSynthez JV-Interfax
Monday, 21 Jul 2014 07:47am EDT 

Farmsintez OAO:Farmsintez OAO and the National Academy of Sciences of Belarus constructed a biotechnological plant in Minsk, Belarus as part of the PrimeSynthez joint venture-Interfax.Dmitry Genkin, the chairman of Pharmsynthez's board of directors, told Interfax that the factory is preparing to be commissioned.He did not specify which medications and in what volume they would be produced.Products will be sold in Belarus and Russia.The construction of the plant began four or five years ago according to Genkin.He declined to name the investments in it.The partners each own 50 percent of PrimeSynthez.It is not planned to attract new investors to the project.  Full Article

Farmsintez OAO appoints general director-Interfax
Tuesday, 27 May 2014 01:40am EDT 

Farmsintez OAO:The board of directors at Farmsintez OAO has appointed Petr Kruglyakov as general director, the company said in a statement-Interfax.Kruglyakov had been managing director for two years, Dmitry Genkin, the board chairman, told Interfax.Kruglyakov was named general director for five years beginning on June 3 until June 2, 2019.He will replace Vadim Romanov, the company's general director since 2007.  Full Article

Farmsintez OAO recommends no FY 2013 dividend payment-Interfax
Monday, 26 May 2014 01:53am EDT 

Farmsintez OAO:The board of directors of Farmsintez OAO has recommended that shareholders waive dividends for 2013 owing to last year's net loss, the company said in a statement-Interfax.Farmsintez OAO AGM will be held on June 24.Farmsintez OAO posted a net loss of 3.407 million Russian rubles in 2013 under Russian accounting standards compared with a net profit of 2.07 million rubles in 2012.If shareholders agree to waive dividends for 2013, it will be the fourth straight year the company has not paid a dividend.  Full Article

Farmsintez OAO to terminate CEO's powers ahead of schedule-Interfax
Wednesday, 21 May 2014 03:54am EDT 

Farmsintez OAO:The board of directors of Farmsintez OAO will terminate the powers of the company's CEO ahead of schedule on May 26 and elect a new head, the company said in a statement-Interfax.Vadim Romanov has headed Farmsintez OAO since 2007.According to the company's charter, the CEO is elected by the board of directors for a term of five years.  Full Article

Farmsintez OAO buys 3.3 pct of research firm IceGen LLC-Interfax
Monday, 17 Feb 2014 09:59pm EST 

Farmsintez OAO:Farmsintez OAO has acquired direct control of 3.3 percent of shares in IceGen LLC in a deal that was closed Feb. 14, the Russian pharmaceuticals company said-Interfax.IceGen does R&D in the area of natural and technical sciences, and also produces food enzymes, chemical substances and pharmaceutical products.IceGen's main shareholder is the Human Stem Cells Institute with 48.07 percent.  Full Article

Farmsintez OAO to Raise RUB 1.1 Billion in Supplementary Share Placement-Interfax
Wednesday, 4 Sep 2013 08:48am EDT 

Interfax reported that Farmsintez OAO (Pharmsynthez) plans to place 50 million supplementary shares in favor of Opko Pharmaceutical (Opko) and the Eurohelp law firm (Estonia). The shares will be placed for RUB 22.08 each, or a total of RUB 1.1 billion, according to materials prepared for a shareholders meeting scheduled for September 18 to vote on the placement. Pharmsynthez expects Eurohelp to buy 37,998,189 shares and Opko to buy 12,001,811. Based on those figures, Eurohelp's post-placement stake in Pharmsynthez would amount to 21.73% and Opko's would rise to 14.63% from 10.88% currently. One main shareholder in Pharmsynthez, the Rusnano state corporation, may exercise preemptive rights to purchase shares, Pharmsynthez board chairman Mr. Dmitry Genkin told Interfax. Rusnano currently owns 29.75% of shares. Another shareholder, Estonian EphaG AS, has 39.66%. The supplementary placement will boost Pharmsynthez charter capital 40% to RUB 874.247 million.  Full Article

Farmsintez OAO Appoints Auditor-SKRIN
Thursday, 27 Jun 2013 10:43am EDT 

SKRIN reported that Farmsintez OAO has appointed Aleks Audit Konsalt OOO as its auditor.  Full Article

Ephag AS Decreases Stake in Farmsintez OAO-AK&M
Monday, 3 Jun 2013 08:00pm EDT 

AK&M reported that Ephag AS (Estonia) has decreased its stake in Farmsintez OAO to 39.6622% from 66.8040%. Further details were not disclosed.  Full Article

ОРКО Pharmaseuticals, LLC Increases Stake in Farmsintez OAO-AK&M
Monday, 3 Jun 2013 08:00pm EDT 

AK&M reported that ОРКО Pharmaseuticals, LLC (Miami) has increased its stake in Farmsintez OAO to 10.8828% (13,587,072 shares) from 0.000001% (1 share). Further details were not disclosed.  Full Article

Rosnano OAO Increases Stake in Farmsintez OAO-AK&M
Sunday, 2 Jun 2013 08:00pm EDT 

AK&M reported that on May 30, 2013 Rosnano OAO increased its stake in Farmsintez OAO from 0.000001% (1 share) to 29.7462% (37,137,995 shares).  Full Article

No consensus analysis data available.
Search Stocks